Recro Pharma, Inc. (REPH) stock trades 1.38% above oppose to SMA-200

Recro Pharma, Inc. (REPH) recently closed with rise of 22.89% to its 20-Day Simple Moving Average. This short time frame picture represents an upward movement of current price over average price of last 20 days. Now moving toward intermediate time frame, 50-day Moving average is more useful at showing position trading trends lasting 50 days. Shares of REPH moved upward with change of 40.11% to its 50-day Moving average. This rising movement shows positive prices direction over last 50 days. REPH stock price revealed optimistic move of 1.38% comparing average price of last 200 days. This comparison showed up direction of price above its 200-SMA. Recro Pharma, Inc. (REPH) stock price moved Upswing along with the volume 0.19 million shares in Yesterday session. Shares are clocking price at $8.50 with change of 2.16%.

Current trade price levels places REPH’s stock about -34.87% away from the 52-week high and closed 77.82% away from the 52-week low. The total dollar value of all 21.46 million outstanding shares is 0.18 billion. The company’s 3-months average volume stands at 0.19 million. When we divide the last trade volume by the 3-month average volume, we found out a relative volume of 0.98.

Currently Analysts have a mean recommendation of 1.60 on the shares. This is based on a 1-5 numeric scale where Rating Scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell, 5.0 Strong Sell.

The beta factor is -0.92.Volatility shows sense of how far the stock will fall if the market takes a dive and how high stock will rise if the bull starts to climb. A stock with a beta more than 1 means high volatile and less than 1 means low volatile.

Common shareholders want to know how profitable their capital is in the businesses they invest it in. The company gives a ROE of -182.80%. The higher the ROE, the better the company is at generating profits.

ROI is -37.10%. A positive result means that returns exceed costs. Analysts therefore consider the investment a net gain. The opposite kind of result, a negative means that costs outweigh returns. Analysts therefore view the investment as a net loss.

Investors saw a positive move of 0.71% in last five trading days. This performance is snap optimistic view of last week. The stock is remained in positive radar as stock is rising. Going back previous 30 days we noticed that REPH performed along premium change of 42.62%. This booming movement indicates the picture of whole previous month is healthy. Currently Recro Pharma, Inc. (REPH) stock is moving with Upswing trend.

Going move backward a period of six month analysis we come to know that stock dipped -19.20% giving falling alert for Investors. Now we take an assessment of last twelve months period, where stock moved higher with performance of 10.68%. Investors also expect the good YTD performance from the stock. From the start of year 2018 to present date REPH reported slumped performance of -8.11%.

Mitchell Cole

Mitchell Cole

Mitchell Cole: Financial Reporter I am Mitchell Cole and i’m passionate about business and finance news with over 6 years in the industry starting as a writer working my way up into senior positions. I am the driving force behind nasdaqplace.com with a vision to broaden the company’s readership throughout 2016. I am an editor and reporter of “Financial” category. Address: 3874 Highland Drive Milwaukee, WI 53202 Phone: 920-681-7526 Email: mitchell@nasdaqplace.com

Leave a Reply

Your email address will not be published. Required fields are marked *